The NF-κB regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells

被引:81
作者
Bauer, Anette
Villunger, Andreas
Labi, Verena
Fischer, Silke F.
Strasser, Andreas
Wagner, Hermann
Schmid, Roland M.
Haecker, Georg
机构
[1] Tech Univ Munich, Inst Med Microbiol, D-81675 Munich, Germany
[2] Innsbruck Med Univ, Div Dev Immunol, Bioctr, A-6020 Innsbruck, Austria
[3] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
[4] Tech Univ Munich, Dept Internal Med 2, D-81675 Munich, Germany
关键词
adjuvant; apoptosis; Bcl-2-family; survival;
D O I
10.1073/pnas.0603625103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
//Apoptosis of activated T cells is critical for the termination of immune responses. Here we show that adjuvant-stimulated dendritic cells secrete cytokines that prime activated T cells for survival and analyze the roles of the NF-kappa B regulator Bcl-3 and the proapoptotic Bcl-2 family members Bim and Puma. Bcl-3 overexpression increased survival, and activated bcl-3(-/-) T cells died abnormally rapidly. Cytokines from adjuvant-stimulated dendritic cells induced Bcl-3, but survival through cytokine priming was Bcl-3-independent. Apoptosis inhibition by Bcl-3 involved blockade of Bim activation, because Bim was overactivated in Bcl-3-deficient cells, and Bcl-3 failed to increase survival of bim(-/-) T cells. However, adjuvants increased survival also in Bim-deficient T cells. This Bim-independent death pathway is at least in part regulated by Puma, as shown by analysis of puma(-/-) and noxa(-/-) T cells. IL-1, IL-7, and IL-15 primed T cells for survival even in the absence of Bim or Puma. Our data define interrelations and a Bim-independent pathway to activated T cell death.
引用
收藏
页码:10979 / 10984
页数:6
相关论文
共 36 条
  • [1] Ways of dying: multiple pathways to apoptosis
    Adams, JM
    [J]. GENES & DEVELOPMENT, 2003, 17 (20) : 2481 - 2495
  • [2] Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim
    Akiyama, T
    Bouillet, P
    Miyazaki, T
    Kadono, Y
    Chikuda, H
    Chung, UG
    Fukuda, A
    Hikita, A
    Seto, H
    Okada, T
    Inaba, T
    Sanjay, A
    Baron, R
    Kawaguchi, H
    Oda, H
    Nakamura, K
    Strasser, A
    Tanaka, S
    [J]. EMBO JOURNAL, 2003, 22 (24) : 6653 - 6664
  • [3] Bates P.W, 2004, Sci STKE, V2004, pp, DOI [10.1126/stke.2542004pe48, DOI 10.1126/STKE.2542004PE48]
  • [4] Proapoptotic Bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
    Bouillet, P
    Metcalf, D
    Huang, DCS
    Tarlinton, DM
    Kay, TWH
    Köntgen, F
    Adams, JM
    Strasser, A
    [J]. SCIENCE, 1999, 286 (5445) : 1735 - 1738
  • [5] Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1
    Dijkers, PF
    Medema, RH
    Lammers, JWJ
    Koenderman, L
    Coffer, PJ
    [J]. CURRENT BIOLOGY, 2000, 10 (19) : 1201 - 1204
  • [6] Bim is a suppressor of Myc-induced mouse B cell leukemia
    Egle, A
    Harris, AW
    Bouillet, P
    Cory, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) : 6164 - 6169
  • [7] The pathophysiology of mitochondrial cell death
    Green, DR
    Kroemer, G
    [J]. SCIENCE, 2004, 305 (5684) : 626 - 629
  • [8] Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals
    Han, JW
    Flemington, C
    Houghton, AB
    Gu, ZM
    Zambetti, GP
    Lutz, RJ
    Zhu, L
    Chittenden, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) : 11318 - 11323
  • [9] Activated T cell death in vivo mediated by proapoptotic Bcl-2 family member Bim
    Hildeman, DA
    Zhu, YN
    Mitchell, TC
    Bouillet, P
    Strasser, A
    Kappler, J
    Marrack, P
    [J]. IMMUNITY, 2002, 16 (06) : 759 - 767
  • [10] Puma is an essential mediator of p53-dependent and -independent apoptotic pathways
    Jeffers, JR
    Parganas, E
    Lee, Y
    Yang, CY
    Wang, JL
    Brennan, J
    MacLean, KH
    Han, JW
    Chittenden, T
    Ihle, JN
    McKinnon, PJ
    Cleveland, JL
    Zambetti, GP
    [J]. CANCER CELL, 2003, 4 (04) : 321 - 328